Sale
Canine PRLR Protein (PLR-DM201)
$270.00 – $900.00
KACTUS Biosystems Canine PRLR Protein (PLR-DM201) (catalog No. PLR-DM201) is expressed from HEK293 with hFc tag at the C-Terminus.It contains Gln25-Thr235.
SKU: PLR-DM201
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | PLR-DM201 |
|---|---|
| Product Name | Canine PRLR Protein (PLR-DM201) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Synonyms | PRL-R; HPRL; MFAB; Prolactin R |
| Species | Canine |
| Source | HEK293 |
| Accession | XM_038663941.1 |
| Product Tag | C-hFc |
| Biotinylated | no |
| Exact Sequence | Gln25-Thr235 |
| Molecular Weight | The protein has a predicted MW of 53.89 kDa. Due to glycosylation, the protein migrates to 65-70 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
PLR-DM201: Canine PRLR Protein (PLR-DM201)
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.
Please remember our product information: Canine PRLR Protein (PLR-DM201) catalog number: PLR-DM201 KACTUS Biosystems
Additional information
| Ship from Country | USA |
|---|---|
| Size | 100 ug, 500 ug |
No more offers for this product!
